Neogen ROE 2010-2025 | NEOG
Current and historical return on equity (ROE) values for Neogen (NEOG) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Neogen ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-02-28 | $-0.49B | $2.66B | -16.71% |
| 2024-11-30 | $-0.48B | $2.67B | -15.74% |
| 2024-08-31 | $-0.02B | $3.14B | -0.73% |
| 2024-05-31 | $-0.01B | $3.14B | -0.25% |
| 2024-02-29 | $0.00B | $3.15B | 0.10% |
| 2023-11-30 | $0.01B | $3.15B | 0.41% |
| 2023-08-31 | $-0.03B | $3.15B | -0.83% |
| 2023-05-31 | $-0.02B | $3.13B | -0.90% |
| 2023-02-28 | $-0.01B | $3.13B | -0.70% |
| 2022-11-30 | $-0.02B | $3.11B | -1.18% |
| 2022-08-31 | $0.04B | $0.88B | 4.10% |
| 2022-05-31 | $0.05B | $0.89B | 5.51% |
| 2022-02-28 | $0.05B | $0.88B | 5.70% |
| 2021-11-30 | $0.06B | $0.87B | 6.77% |
| 2021-08-31 | $0.06B | $0.86B | 7.56% |
| 2021-05-31 | $0.06B | $0.84B | 7.68% |
| 2021-02-28 | $0.06B | $0.81B | 7.97% |
| 2020-11-30 | $0.06B | $0.78B | 8.09% |
| 2020-08-31 | $0.06B | $0.75B | 8.33% |
| 2020-05-31 | $0.06B | $0.73B | 8.46% |
| 2020-02-29 | $0.06B | $0.71B | 8.74% |
| 2019-11-30 | $0.06B | $0.69B | 9.20% |
| 2019-08-31 | $0.06B | $0.66B | 9.52% |
| 2019-05-31 | $0.06B | $0.64B | 9.83% |
| 2019-02-28 | $0.06B | $0.62B | 10.49% |
| 2018-11-30 | $0.07B | $0.60B | 11.55% |
| 2018-08-31 | $0.07B | $0.58B | 12.15% |
| 2018-05-31 | $0.06B | $0.56B | 12.13% |
| 2018-02-28 | $0.06B | $0.54B | 11.47% |
| 2017-11-30 | $0.05B | $0.52B | 10.56% |
| 2017-08-31 | $0.05B | $0.49B | 9.75% |
| 2017-05-31 | $0.04B | $0.47B | 9.68% |
| 2017-02-28 | $0.04B | $0.45B | 9.60% |
| 2016-11-30 | $0.04B | $0.44B | 9.49% |
| 2016-08-31 | $0.04B | $0.42B | 9.33% |
| 2016-05-31 | $0.04B | $0.40B | 9.38% |
| 2016-02-29 | $0.04B | $0.39B | 9.44% |
| 2015-11-30 | $0.03B | $0.38B | 9.50% |
| 2015-08-31 | $0.03B | $0.37B | 9.56% |
| 2015-05-31 | $0.03B | $0.35B | 9.90% |
| 2015-02-28 | $0.03B | $0.34B | 9.93% |
| 2014-11-30 | $0.03B | $0.33B | 10.30% |
| 2014-08-31 | $0.03B | $0.32B | 10.02% |
| 2014-05-31 | $0.03B | $0.31B | 10.09% |
| 2014-02-28 | $0.03B | $0.29B | 10.16% |
| 2013-11-30 | $0.03B | $0.28B | 10.60% |
| 2013-08-31 | $0.03B | $0.27B | 11.45% |
| 2013-05-31 | $0.03B | $0.26B | 11.53% |
| 2013-02-28 | $0.03B | $0.25B | 11.59% |
| 2012-11-30 | $0.03B | $0.24B | 11.16% |
| 2012-08-31 | $0.02B | $0.23B | 10.69% |
| 2012-05-31 | $0.02B | $0.22B | 10.62% |
| 2012-02-29 | $0.02B | $0.21B | 11.01% |
| 2011-11-30 | $0.02B | $0.20B | 11.47% |
| 2011-08-31 | $0.02B | $0.20B | 12.50% |
| 2011-05-31 | $0.02B | $0.19B | 13.14% |
| 2011-02-28 | $0.02B | $0.18B | 13.25% |
| 2010-11-30 | $0.02B | $0.17B | 13.29% |
| 2010-08-31 | $0.02B | $0.16B | 13.29% |
| 2010-05-31 | $0.02B | $0.15B | 12.50% |
| 2010-02-28 | $0.02B | $0.15B | 11.59% |
| 2009-11-30 | $0.02B | $0.14B | 11.30% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.953B | $0.924B |
| Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $227.162B | 27.40 |
| Boston Scientific (BSX) | United States | $140.689B | 37.90 |
| Stryker (SYK) | United States | $132.255B | 28.42 |
| EssilorLuxottica (ESLOY) | France | $128.431B | 0.00 |
| Medtronic (MDT) | Ireland | $105.938B | 15.47 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.424B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.151B | 26.20 |
| ResMed (RMD) | United States | $31.269B | 24.08 |
| Agilent Technologies (A) | United States | $29.217B | 19.30 |
| GE HealthCare Technologies (GEHC) | United States | $28.556B | 13.89 |
| Terumo (TRUMY) | Japan | $28.160B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.192B | 15.85 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.373B | 12.24 |
| Insulet (PODD) | United States | $17.332B | 74.11 |
| Baxter (BAX) | United States | $14.818B | 10.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.356B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $7.609B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.938B | 17.06 |
| Bio-Rad Laboratories (BIO) | United States | $6.672B | 23.10 |
| Demant (WILYY) | Denmark | $6.644B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.977B | 18.98 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.455B | 9.89 |
| ICU Medical (ICUI) | United States | $3.400B | 29.07 |
| Haemonetics (HAE) | United States | $2.872B | 13.52 |
| Envista Holdings (NVST) | United States | $2.614B | 20.80 |
| GN Store Nord (GNNDY) | Denmark | $2.188B | 14.75 |
| LeMaitre Vascular (LMAT) | United States | $1.946B | 44.47 |
| QuidelOrtho (QDEL) | United States | $1.698B | 14.22 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.214B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.189B | 18.67 |
| AdaptHealth (AHCO) | United States | $1.051B | 10.12 |
| BioLife Solutions (BLFS) | United States | $1.041B | 0.00 |
| InMode (INMD) | Israel | $1.038B | 8.67 |
| Phibro Animal Health (PAHC) | United States | $0.700B | 10.74 |
| Evolus (EOLS) | United States | $0.686B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.649B | 0.00 |
| Valneva SE (VALN) | France | $0.552B | 0.00 |
| Owens & Minor (OMI) | United States | $0.535B | 4.56 |
| CeriBell (CBLL) | United States | $0.532B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.514B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.450B | 0.00 |
| Surmodics (SRDX) | United States | $0.394B | 0.00 |
| Omeros (OMER) | United States | $0.394B | 0.00 |
| SNDL (SNDL) | Canada | $0.368B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.302B | 13.07 |
| Viemed Healthcare (VMD) | United States | $0.262B | 23.68 |
| Sanara MedTech (SMTI) | United States | $0.262B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 15.65 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.251B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 44.40 |
| Cerus (CERS) | United States | $0.242B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Quanterix (QTRX) | United States | $0.200B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Biote (BTMD) | United States | $0.181B | 4.12 |
| TriSalus Life Sciences (TLSI) | United States | $0.175B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.172B | 13.24 |
| Brainsway (BWAY) | Israel | $0.155B | 48.47 |
| Jin Medical (ZJYL) | China | $0.147B | 0.00 |
| Organigram Global (OGI) | Canada | $0.135B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.42 |
| Agape ATP (ATPC) | $0.094B | 0.00 | |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.083B | 0.00 |
| Exagen (XGN) | United States | $0.080B | 0.00 |
| MacroGenics (MGNX) | United States | $0.079B | 0.00 |
| Veru (VERU) | United States | $0.078B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.65 |
| Zynex (ZYXI) | United States | $0.066B | 24.22 |
| United Health Products (UEEC) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 11.61 |
| Apyx Medical (APYX) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.035B | 51.50 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.010B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |